Basal Forebrain Activation Improves Working Memory in Senescent Monkeys

Overview

Journal bioRxiv

Date 2024 Nov 22

PMID 39574741

Authors

Kendyl R Pennington

Luca Debs

Sophia Chung

Janki Bava

Clement M Garin

Fernando L Vale

Sarah K Bick

Dario J Englot

Alvin V Terry Jr

Christos Constantinidis

David T Blake

Affiliations

Soon will be listed here.

Abstract

Brain aging contributes to cognitive decline and risk of dementia. Degeneration of the basal forebrain cholinergic system parallels these changes in aging, Alzheimer's dementia, Parkinson's dementia, and Lewy body dementia, and thus is a common element linked to executive function across the lifespan and in disease states. Here, we tested the potential of one-hour daily intermittent basal forebrain stimulation to improve cognition in senescent monkeys, and its mechanisms of action. Stimulation in five animals improved working memory duration in 8-12 weeks across all animals, with peak improvements observed in the first four weeks. In an ensuing three month period without stimulation, improvements were retained. With additional stimulation, performance remained above baseline throughout the 15 months of the study. Studies with a cholinesterase inhibitor produced inconsistent improvements in behavior. One of five animals improved significantly. Manipulating the stimulation pattern demonstrated selectivity for both stimulation and recovery period duration. Brain stimulation led to acute increases in cerebrospinal levels of tissue plasminogen activator, which is an activating element for two brain neurotrophins, Nerve Growth Factor (NGF) and Brain-Derived Growth Factor (BDNF). Stimulation also led to improved glucose utilization in stimulated hemispheres relative to contralateral. Glucose utilization also consistently declines with aging and some dementias. Together, these findings suggest that intermittent stimulation of the nucleus basalis of Meynert improves executive function and reverses some aspects of brain aging.

References

Andersen P, Sundberg S, Sveen O, Wigstrom H . Specific long-lasting potentiation of synaptic transmission in hippocampal slices. Nature. 1977; 266(5604):736-7. DOI: 10.1038/266736a0. View

Liu R, Crawford J, Callahan P, Terry Jr A, Constantinidis C, Blake D . Intermittent Stimulation of the Nucleus Basalis of Meynert Improves Working Memory in Adult Monkeys. Curr Biol. 2017; 27(17):2640-2646.e4. PMC: 5759307. DOI: 10.1016/j.cub.2017.07.021. View

Bruno M, Cuello A . Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc Natl Acad Sci U S A. 2006; 103(17):6735-40. PMC: 1458950. DOI: 10.1073/pnas.0510645103. View

Histed M, Bonin V, Reid R . Direct activation of sparse, distributed populations of cortical neurons by electrical microstimulation. Neuron. 2009; 63(4):508-22. PMC: 2874753. DOI: 10.1016/j.neuron.2009.07.016. View

Cagnan H, Denison T, McIntyre C, Brown P . Emerging technologies for improved deep brain stimulation. Nat Biotechnol. 2019; 37(9):1024-1033. PMC: 6877347. DOI: 10.1038/s41587-019-0244-6. View

Ishibashi K, Onishi A, Wagatsuma K, Fujiwara Y, Ishii K . Longitudinal 18F-FDG Images in Patients With Alzheimer Disease Over More Than 9 Years From a Preclinical Stage. Clin Nucl Med. 2020; 45(4):e185-e189. DOI: 10.1097/RLU.0000000000002948. View

Hotta H, Kagitani F, Kondo M, Uchida S . Basal forebrain stimulation induces NGF secretion in ipsilateral parietal cortex via nicotinic receptor activation in adult, but not aged rats. Neurosci Res. 2008; 63(2):122-8. DOI: 10.1016/j.neures.2008.11.004. View

Gratwicke J, Kahan J, Zrinzo L, Hariz M, Limousin P, Foltynie T . The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia?. Neurosci Biobehav Rev. 2013; 37(10 Pt 2):2676-88. DOI: 10.1016/j.neubiorev.2013.09.003. View

Cole E, Stimpson K, Bentzley B, Gulser M, Cherian K, Tischler C . Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression. Am J Psychiatry. 2020; 177(8):716-726. DOI: 10.1176/appi.ajp.2019.19070720. View

10.

Sasikumar S, Cohn M, Harmsen I, Loh A, Cho S, Saenz-Farret M . Single-Trajectory Multiple-Target Deep Brain Stimulation for Parkinsonian Mobility and Cognition. Mov Disord. 2021; 37(3):635-640. DOI: 10.1002/mds.28870. View

11.

Verger A, Doyen M, Campion J, Guedj E . The pons as reference region for intensity normalization in semi-quantitative analysis of brain FDG PET: application to metabolic changes related to ageing in conventional and digital control databases. EJNMMI Res. 2021; 11(1):31. PMC: 7990981. DOI: 10.1186/s13550-021-00771-0. View

12.

Kumro J, Tripathi A, Lei Y, Sword J, Callahan P, Terry A . Chronic basal forebrain activation improves spatial memory, boosts neurotrophin receptor expression, and lowers BACE1 and Aβ42 levels in the cerebral cortex in mice. Cereb Cortex. 2023; 33(12):7627-7641. PMC: 10267632. DOI: 10.1093/cercor/bhad066. View

13.

Burns A, Yeates A, Akintade L, Del Valle M, Zhang R, Schwam E . Defining treatment response to donepezil in Alzheimer's disease: responder analysis of patient-level data from randomized, placebo-controlled studies. Drugs Aging. 2008; 25(8):707-14. DOI: 10.2165/00002512-200825080-00007. View

14.

Colman R . Non-human primates as a model for aging. Biochim Biophys Acta Mol Basis Dis. 2017; 1864(9 Pt A):2733-2741. PMC: 5772001. DOI: 10.1016/j.bbadis.2017.07.008. View

15.

Grothe M, Schuster C, Bauer F, Heinsen H, Prudlo J, Teipel S . Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia. J Neurol. 2014; 261(10):1939-48. DOI: 10.1007/s00415-014-7439-z. View

16.

Willis A, Pratt J, Morris B . BDNF and JNK Signaling Modulate Cortical Interneuron and Perineuronal Net Development: Implications for Schizophrenia-Linked 16p11.2 Duplication Syndrome. Schizophr Bull. 2020; 47(3):812-826. PMC: 8084442. DOI: 10.1093/schbul/sbaa139. View

17.

Pentz R, Iulita M, Ducatenzeiler A, Bennett D, Cuello A . The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease. Mol Psychiatry. 2020; 26(10):6023-6037. PMC: 10194044. DOI: 10.1038/s41380-020-0797-2. View

18.

Liu R, Crawford J, Callahan P, Terry A, Constantinidis C, Blake D . Intermittent stimulation in the nucleus basalis of meynert improves sustained attention in rhesus monkeys. Neuropharmacology. 2018; 137:202-210. PMC: 6553880. DOI: 10.1016/j.neuropharm.2018.04.026. View

19.

Grothe M, Zaborszky L, Atienza M, Gil-Neciga E, Rodriguez-Romero R, Teipel S . Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. Cereb Cortex. 2009; 20(7):1685-95. PMC: 2912653. DOI: 10.1093/cercor/bhp232. View

20.

LEVITT H . Transformed up-down methods in psychoacoustics. J Acoust Soc Am. 1971; 49(2):Suppl 2:467+. View